Silk Road Medical Statistics
Total Valuation
SHE:301616 has a market cap or net worth of CNY 4.55 billion. The enterprise value is 4.10 billion.
Market Cap | 4.55B |
Enterprise Value | 4.10B |
Important Dates
The last earnings date was Monday, July 28, 2025.
Earnings Date | Jul 28, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SHE:301616 has 80.00 million shares outstanding. The number of shares has decreased by -0.02% in one year.
Current Share Class | 80.00M |
Shares Outstanding | 80.00M |
Shares Change (YoY) | -0.02% |
Shares Change (QoQ) | -3.17% |
Owned by Insiders (%) | 60.33% |
Owned by Institutions (%) | 1.86% |
Float | 21.39M |
Valuation Ratios
The trailing PE ratio is 38.48.
PE Ratio | 38.48 |
Forward PE | n/a |
PS Ratio | 4.86 |
PB Ratio | 3.42 |
P/TBV Ratio | 3.55 |
P/FCF Ratio | n/a |
P/OCF Ratio | 70.15 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.93, with an EV/FCF ratio of -1,259.64.
EV / Earnings | 42.74 |
EV / Sales | 4.37 |
EV / EBITDA | 23.93 |
EV / EBIT | 35.34 |
EV / FCF | -1,259.64 |
Financial Position
The company has a current ratio of 2.50, with a Debt / Equity ratio of 0.07.
Current Ratio | 2.50 |
Quick Ratio | 1.89 |
Debt / Equity | 0.07 |
Debt / EBITDA | 0.53 |
Debt / FCF | -28.12 |
Interest Coverage | 13.35 |
Financial Efficiency
Return on equity (ROE) is 8.76% and return on invested capital (ROIC) is 5.72%.
Return on Equity (ROE) | 8.76% |
Return on Assets (ROA) | 4.55% |
Return on Invested Capital (ROIC) | 5.72% |
Return on Capital Employed (ROCE) | 8.49% |
Revenue Per Employee | 597,567 |
Profits Per Employee | 61,132 |
Employee Count | 1,569 |
Asset Turnover | 0.59 |
Inventory Turnover | 2.69 |
Taxes
In the past 12 months, SHE:301616 has paid 17.36 million in taxes.
Income Tax | 17.36M |
Effective Tax Rate | 15.24% |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 43.20 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 67.09 |
Average Volume (20 Days) | 3,713,337 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301616 had revenue of CNY 937.58 million and earned 95.92 million in profits. Earnings per share was 1.48.
Revenue | 937.58M |
Gross Profit | 234.93M |
Operating Income | 115.98M |
Pretax Income | 113.91M |
Net Income | 95.92M |
EBITDA | 165.10M |
EBIT | 115.98M |
Earnings Per Share (EPS) | 1.48 |
Balance Sheet
The company has 548.30 million in cash and 91.51 million in debt, giving a net cash position of 456.79 million or 5.71 per share.
Cash & Cash Equivalents | 548.30M |
Total Debt | 91.51M |
Net Cash | 456.79M |
Net Cash Per Share | 5.71 |
Equity (Book Value) | 1.33B |
Book Value Per Share | 16.54 |
Working Capital | 733.19M |
Cash Flow
In the last 12 months, operating cash flow was 64.90 million and capital expenditures -68.16 million, giving a free cash flow of -3.25 million.
Operating Cash Flow | 64.90M |
Capital Expenditures | -68.16M |
Free Cash Flow | -3.25M |
FCF Per Share | -0.04 |
Margins
Gross margin is 25.06%, with operating and profit margins of 12.37% and 10.23%.
Gross Margin | 25.06% |
Operating Margin | 12.37% |
Pretax Margin | 12.15% |
Profit Margin | 10.23% |
EBITDA Margin | 17.61% |
EBIT Margin | 12.37% |
FCF Margin | n/a |
Dividends & Yields
SHE:301616 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 8.70% |
Buyback Yield | 0.02% |
Shareholder Yield | n/a |
Earnings Yield | 2.11% |
FCF Yield | -0.07% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 4 |